Machine Learning Predictor of Immune Checkpoint Blockade Response in Gastric Cancer
Predicting responses to immune checkpoint blockade (ICB) lacks official standards despite the discovery of several markers. Expensive drugs and different reactivities for each patient are the main disadvantages of immunotherapy. Gastric cancer is refractory and stem-like in nature and does not respo...
Main Authors: | Ji-Yong Sung, Jae-Ho Cheong |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-06-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/13/3191 |
Similar Items
-
Towards a precision immune checkpoint blockade immunotherapy in patients with colorectal cancer: Strategies and perspectives
by: Guanglin Cui
Published: (2022-05-01) -
Bioinformatics analysis of the prognosis and biological significance of VCAN in gastric cancer
by: Xiao‐yan Huang, et al.
Published: (2021-06-01) -
Recent Advances in Glioma Therapy: Combining Vascular Normalization and Immune Checkpoint Blockade
by: Rachel L. Y. Ho, et al.
Published: (2021-07-01) -
Immune Checkpoint Blockades in Triple-Negative Breast Cancer: Current State and Molecular Mechanisms of Resistance
by: Hyungjoo Kim, et al.
Published: (2022-05-01) -
Versican enrichment predicts poor prognosis and response to adjuvant therapy and immunotherapy in gastric cancer
by: Junquan Song, et al.
Published: (2022-09-01)